WHO hosts historic meeting to address global oral health challenges

Plus, news about Ko­di­ak Sci­ences, Out­look Ther­a­peu­tics and Avac­ta: Boehringer In­gel­heim re­ports Phase 3 schiz­o­phre­nia fail: The drug, icleper­tin, Sign up to read this article

Roche is buy­ing in­to a mid-stage car­dio­vas­cu­lar drug can­di­date out of Al­ny­lam’s RNAi plat­form in a deal that starts with $310 mil­lion up­front and could

Regularly drinking sugar-sweetened beverages was associated with a significantly increased incidence of liver cancer and death from chronic liver disease, according to a prospective cohort